Universal Ibogaine Inc. IBOGF
Set alert
0.00 USD 0.00 0.00%
At close · Nov 2
0.008 Day range 0.008
0.00001 52-week range 0.35
- YTD
- -96.97%
- 1 year
- -98.18%
- Open
- 0.008
- Prev close
- 0.0001
- Mkt cap
- 31.29K
- Vol
- 9.50K
- Avg vol
- 176.81K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.008
- High
- 0.008
2Y chart
Signals (98)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 17, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 5, 2026 | 5 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
Newest 20 of 98.
News
- Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
- Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
- Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
- Universal Ibogaine advises further on application for Management Cease Trade Order
- Universal Ibogaine Advises of Filing Application for Management Cease Trade Order
- Universal Ibogaine Provides Corporate Update
- Universal Ibogaine Announces Board Changes
- Universal Ibogaine Announces Results of the Annual Meeting of Shareholders
- Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply
- Universal Ibogaine advises of appointment of two new Board Members
Your note
Sign in to keep a note on IBOGF — it syncs with the Stock Master app.